Press releases
- Dexcom Reports First Quarter 2024 Financial Results
- Dexcom Publishes Annual Sustainability Report
- Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
- Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter
- Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD
- Dexcom Announces Upcoming Conference Presentation
More ▼
Key statistics
On Friday, DEXCOM INC DRN (D1EX34:SAO) closed at 13.27, -8.17% below its 52-week high of 14.45, set on Apr 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 13.27 |
---|---|
High | 13.27 |
Low | 13.27 |
Bid | 11.50 |
Offer | 14.82 |
Previous close | 13.27 |
Average volume | 309.71 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of May 10 2024 20:54 BST.
More ▼